Manufacturing Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing Pharmaceutical TechnologyWhen Eli Lilly's Lebanon campus is complete, it will manufacture several of the pharma's APIs and genetic medicines to serve US patients.Read full story pharminent May 7, 2026 (Last updated: May 8, 2026) Pharmaceutical Technology When Eli Lilly’s Lebanon campus is complete, it will manufacture several of the pharma’s APIs and genetic medicines to serve US patients. Read full story Post navigation Previous: Daiichi Sankyo and Waiv partner for ADC biomarkersNext: UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies Related Stories Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026 Manufacturing Multispecifics are transforming the CDMO development architecture pharminent August 28, 2026